Methods for treatment of bone marrow failure and related conditions
AssigneeImago Biosciences, Inc.
InventorsMaria Kleppe, Hugh Y. Rienhoff, JR., Jennifer Dias
Life of this patent
Estimating the term…
Loading patent…
AssigneeImago Biosciences, Inc.
InventorsMaria Kleppe, Hugh Y. Rienhoff, JR., Jennifer Dias
Estimating the term…
Provided herein are methods for increasing the numbers of hematopoietic stem cells (HSCs) in a patient in need thereof, for treating a condition characterized by reduced numbers of hematopoietic stem cells (HSCs), such as bone marrow failure (BMF) or a BMF syndrome, in a patient in need thereof, for enhancing recovery from or improving tolerance of a near-ablative cancer therapy, and/or for reducing the damage to, or accelerating the recovery of, the hematopoietic compartment after a physical insult thereto in a patient in need thereof, comprising administering in vivo or treating cells ex vivo with an LSD1 inhibitor.
A method of increasing the numbers of hematopoietic stem cells in a patient in need thereof comprising i) administering an LSD1 inhibitor to the patient in an amount and/or for a period of time sufficient to result in an in vivo expansion of a population of hematopoietic stem cells;
A method of treating a condition characterized by reduced numbers of hematopoietic stem cells in a patient in need thereof, comprising i) administering an LSD1 inhibitor to the patient in an amount and/or for a period of time sufficient to result in an in vivo expansion of a population of hematopoietic stem cells;
A method of enhancing recovery from a near-ablative cancer therapy comprising, subsequent to such therapy, i) administering an LSD1 inhibitor to the patient in an amount and/or for a period of time sufficient to result in an in vivo expansion of a population of hematopoietic stem cells;
A method of improving tolerance of a near-ablative cancer therapy comprising, prior to such therapy, i) administering an LSD1 inhibitor to the patient in an amount and/or for a period of time sufficient to result in an in vivo expansion of a population of hematopoietic stem cells;
The method of 4, wherein the near-ablative cancer therapy is chosen from therapeutic irradiation of cancer cells and cytotoxic chemotherapy of cancer cells.
A method of reducing the damage to, or accelerating the recovery of, the hematopoietic compartment after a physical insult thereto in a patient in need thereof, comprising i) administering an LSD1 inhibitor to the patient in an amount and/or for a period of time sufficient to result in an in vivo expansion of a population of hematopoietic stem cells;
14-19. (canceled)
24-33. (canceled)
39-49. (canceled)
52-66. (canceled)
(canceled)
Dependencies are inferred from the claim text.